Literature DB >> 20507840

A three-year-analysis of fixed drug eruptions in hospital settings in France.

Nesrine Brahimi1, Emilie Routier, Nadia Raison-Peyron, Anne-Fleur Tronquoy, Caroline Pouget-Jasson, Stéphanie Amarger, Laurent Machet, Emmanuelle Amsler, Antoine Claeys, Bruno Sassolas, Dominique Leroy, Anne Grange, Alain Dupuy, Nadège Cordel, Jean-Marie Bonnetblanc, Brigitte Milpied, Marie-Sylvie Doutre, Marie-Thérèse Guinnepain, Annick Barbaud, Olivier Chosidow, Jean-Claude Roujeau, Bénédicte Lebrun-Vignes, Vincent Descamps.   

Abstract

Fixed drug eruption (FDE) is one of the most typical cutaneous drug adverse reactions. This localized drug-induced reaction is characterized by its relapse at the same sites. Few large series of FDE are reported. The aim of this study was to retrospectively collect and analyse well informed cases observed in a hospital setting. This study involved 17 academic clinical centers. A French nation-wide retrospective multicentric study was carried out on a 3-year-period from 2005 to 2007 by collecting data in seventeen departments of dermatology in France. Diagnosis of FDE was based essentially on clinical findings, at times confirmed by pathological data and patch-testing. Records were reviewed for demographics, causative drugs, localization, severity, and patch-tests, when available. Fifty nine cases were analysed. Patients were 59-years-old on average, with a female predilection. The most common drug was paracetamol, followed by the non-steroidal anti inflammatory drugs. The time between drug intake and skin symptoms was, on average, two days. Beside these classical characteristics, some original findings were found including, a frequent non pigmentation course and a sex-dependent pattern of distribution. Women often had lesions on the hands and feet, and men on the genitalia. Given the fact that skin pigmentation is an inconstant feature of FDE, its French name (erythème pigmenté fixe) should be reconsidered. The sex-dependent distribution could help our understanding of the pathophysiology of fixed drug eruption.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507840     DOI: 10.1684/ejd.2010.0980

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  16 in total

Review 1.  Evaluation of antibiotic allergy: the role of skin tests and drug challenges.

Authors:  Roland Solensky; David A Khan
Journal:  Curr Allergy Asthma Rep       Date:  2014-09       Impact factor: 4.806

2.  Pityriasis rosea-like eruption associated with ondansetron use in pregnancy.

Authors:  Malak M Alame; Dina J Chamsy; Hassan Zaraket
Journal:  Br J Clin Pharmacol       Date:  2018-03-09       Impact factor: 4.335

Review 3.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

Review 4.  Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity.

Authors:  Katherine C Konvinse; Elizabeth J Phillips; Katie D White; Jason A Trubiano
Journal:  Curr Opin Infect Dis       Date:  2016-12       Impact factor: 4.915

5.  Ciprofloxacin induced bullous fixed drug reaction: three case reports.

Authors:  Pragya A Nair
Journal:  J Family Med Prim Care       Date:  2015 Apr-Jun

6.  Cutaneous adverse drug reactions in Indian population: A systematic review.

Authors:  Tejas K Patel; Sejal H Thakkar; Dc Sharma
Journal:  Indian Dermatol Online J       Date:  2014-12

Review 7.  Fixed drug eruption to fluconazole: a case report and review of literature.

Authors:  Varadraj V Pai; Prassanna Bhandari; Naveen Narayanshetty Kikkeri; Sharatchandra B Athanikar; Tukaram Sori
Journal:  Indian J Pharmacol       Date:  2012 Sep-Oct       Impact factor: 1.200

8.  Skin testing and patch testing in non-IgE-mediated drug allergy.

Authors:  Annick Barbaud
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.919

9.  Clinical features of fixed drug eruption at a tertiary hospital in Korea.

Authors:  Jae-Woo Jung; Sang-Heon Cho; Kyu-Han Kim; Kyung-Up Min; Hye-Ryun Kang
Journal:  Allergy Asthma Immunol Res       Date:  2014-03-26       Impact factor: 5.764

10.  Fixed Drug Eruption due to Achiote Dye.

Authors:  Ian Tattersall; Bobby Y Reddy
Journal:  Case Rep Dermatol       Date:  2016-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.